Second Sight begins trading today

• Sylmar, CA-based Second Sight Medical Products (NASDAQ:EYES) debuts today via its IPO of 3.5M shares priced at $9.
• The company develops visual prosthetics to restore some functional vision to blind patients. Its lead product is the Argus II System for the treatment of outer retinal degenerations such as retinitis pigmentosa. It is the only retinal prosthesis approved by the FDA and the first one approved anywhere in the world.
• S-1
• ETFs: IBB, BIB, BIS (NYSEARCA:IPO)